Your Health Plan:
Your Health Plan:
Not SelectedACTEMRA ACTPEN (tocilizumab) is a biologic prescription drug for treatment of Rheumatoid Arthritis, Giant Cell Arteritis, Juvenile polyarthritis, Systemic onset juvenile chronic arthritis, Cytokine Release Syndrome and COVID19 (disease). ACTEMRA ACTPEN is a interleukin-6 receptor antagonist. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $1300-1700.
No saving program is found for ACTEMRA ACTPEN.
Other alternatives to ACTEMRA ACTPEN may include:
